New scan aims to see inside breast cancer tumors
NCT ID NCT07292571
Summary
This study is testing a new imaging method to see how much HER2 protein is present in breast cancer tumors. It involves 50 patients who have not yet started treatment. The goal is to see if a special radioactive tracer can accurately show HER2 levels, which helps doctors choose the right treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cancer Research Institute of Tomsk National Research Medical Center of the Russian Academy of Sciences
Tomsk, Russia
Conditions
Explore the condition pages connected to this study.